menu
    • menu

    Company profile for Candel Therapeutics

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Candel Therapeutics is a Boston-area privately held biopharmaceutical company. We are committed to saving, extending and improving the lives of cancer patients and their families through the development and commercialization of innovative and personalized cancer immunotherapies. At the forefront of these efforts is our proprietary Gene Mediated Cytotoxic Immunotherapy™ (GMCI™), a platform technology designed to stimulate a...
    Candel Therapeutics is a Boston-area privately held biopharmaceutical company. We are committed to saving, extending and improving the lives of cancer patients and their families through the development and commercialization of innovative and personalized cancer immunotherapies. At the forefront of these efforts is our proprietary Gene Mediated Cytotoxic Immunotherapy™ (GMCI™), a platform technology designed to stimulate a patient’s immune system to naturally fight against his or her cancer. GMCI™ is a novel and versatile technology that can be applied to a variety of solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Candel TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    117 Kendrick Street, Suite 450 Needham, Massachusetts 02494
    Telephone
    Telephone
    6179165445
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.candeltx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/candel-therapeutics/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CandelTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Candel Therapeutics Reveals 2025 Financials And Corporate Updates
    Candel Therapeutics Reveals 2025 Financials And Corporate Updates

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254591/0/en/Candel-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Candel Therapeutics Awards Inducement Grants Under Nasdaq Rules
    Candel Therapeutics Awards Inducement Grants Under Nasdaq Rules

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247866/0/en/Candel-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Candel Therapeutics to Present at TD Cowen Healthcare Conference
    Candel Therapeutics to Present at TD Cowen Healthcare Conference

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243548/0/en/Candel-Therapeutics-to-Present-at-TD-Cowen-s-46th-Annual-Health-Care-Conference-in-Boston.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Candel Secures $100M RTW Royalty Deal for CAN-2409
    Candel Secures $100M RTW Royalty Deal for CAN-2409

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241516/0/en/Candel-Therapeutics-Announces-100M-Royalty-Funding-Agreement-with-RTW-to-Support-the-Potential-Launch-of-Aglatimagene-Besadenovec-CAN-2409-in-Localized-Prostate-Cancer.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Candel Announces Proposed $100 Million Public Offering
    Candel Announces Proposed $100 Million Public Offering

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241544/0/en/Candel-Therapeutics-Announces-Proposed-100-Million-Public-Offering.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Candel Therapeutics at 7th Annual GBM Drug Development Summit
    Candel Therapeutics at 7th Annual GBM Drug Development Summit

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236249/0/en/Candel-Therapeutics-to-Present-at-the-7th-Annual-Glioblastoma-Drug-Development-Summit.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search